Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2023-04-25 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南微医学科技股份有限公司董事会审计委员会2022年履职情况报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Board Audit Committee of a company, summarizing their activities and oversight for the fiscal year 2022. It includes descriptions of meetings, evaluations of external auditors, internal audit guidance, financial report reviews, internal control assessments, and related party transaction reviews. The content is focused on the audit committee's duties and their fulfillment over the year, which aligns with an Audit Report / Information filing rather than a full Annual Report or other categories. The document length is 2770 characters, which is relatively short but contains substantive audit-related content, not just an announcement or certification. Therefore, it fits best under the Audit Report / Information (AR) category. FY 2022
2023-04-25 Chinese
南微医学科技股份有限公司第三届董事会第十二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 12th meeting of the 3rd Board of Directors of 南微医学科技股份有限公司, held on April 25, 2023. It includes approvals of various reports and proposals such as the 2022 Annual Report, 2023 Q1 Report, profit distribution, audit committee reports, internal control evaluation, social responsibility report, and others. The document repeatedly states that these resolutions need to be submitted to the 2022 Annual General Meeting for approval. The document is not the reports themselves but a formal board meeting resolution announcement. It also references other announcements published on the Shanghai Stock Exchange website. The document length is 3863 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement of board meeting resolutions and not the actual reports or presentations themselves.
2023-04-25 Chinese
南微医学科技股份有限公司关于2022年度利润分配方案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2022 annual profit distribution plan of the company 南微医学科技股份有限公司. It details the dividend per share, total dividend amount, and the decision-making process including board and supervisory opinions. It explicitly states that the profit distribution plan needs to be submitted to the 2022 annual shareholders' meeting for approval. The document does not contain full financial statements or comprehensive financial performance data but focuses on dividend distribution details and related corporate governance procedures. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2023-04-25 Chinese
南微医学科技股份有限公司2023年第一季度报告
Interim / Quarterly Report Classification · 98% confidence The document is titled '2023 年第一季度报告' which translates to '2023 First Quarter Report'. It contains detailed financial data including income statement, balance sheet, cash flow statement, and notes for the first quarter of 2023. The report is unaudited as indicated. The content includes comprehensive financial metrics, shareholder information, and operational highlights for the quarter. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive financial data and analysis. The document is lengthy (over 14,000 characters) and contains the full financial statements, not just an announcement or summary, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is IR with high confidence. Q1 2023
2023-04-25 Chinese
南微医学科技股份有限公司2022年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2022 年年度报告摘要" which translates to "2022 Annual Report Summary". It contains detailed financial data for the year 2022, including revenue, net profit, earnings per share, and other financial metrics. It also discusses the company's business overview, industry position, risk factors, and future outlook. The document is comprehensive and includes actual financial statements and analysis for the full fiscal year 2022. It is not a brief announcement or a certification letter but a substantive report covering the company's yearly performance. Therefore, it fits the definition of an Annual Report (10-K). FY 2022
2023-04-25 Chinese
中天运会计师事务所（特殊普通合伙）关于南微医学科技股份有限公司2022年度募集资金存放与使用情况的专项报告
Regulatory Filings
2023-04-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.